Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186598 · ClinicalTrials.gov registry record · NA
Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema
A NA study of Continuous Positive Airway Pressure and High Altitude Pulmonary Edema, sponsored by CommonSpirit Health.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT04186598: Completed NA study of Continuous Positive Airway Pressure and High Altitude Pulmonary Edema, sponsored by CommonSpirit Health.
NCT04186598 is a NA study of Continuous Positive Airway Pressure and High Altitude Pulmonary Edema that has completed, run by CommonSpirit Health. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04186598, a NA study of Continuous Positive Airway Pressure and High Altitude Pulmonary Edema, has completed, sponsored by CommonSpirit Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to evaluate the efficacy of continuous positive pressure on resolution of high-altitude pulmonary edema vs high flow oxygen. The secondary objective is to derive an incidence of high-altitude pulmonary edema based on the elevation and timing from which the subject arrives. Additionally, in a convenience sample of the base study population, an ultrasound evaluation for the presence of B lines in the lungs will be conducted after 2 hours.
Primary Outcome
The amount of time it took to maintain oxygen saturation over 92% on 2L NC oxygen
Conditions Studied
Interventions
- DEVICE CPAP mask system
- DRUG Nifedipine 30 MG
- DEVICE CPAP mask system without PEEP
Study Locations (1)
Colorado
- Breckenridge Medical Center - Breckenridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-01-20 |
| Est. Completion | 2023-09-13 |
| Phase | NA |
What the finished NCT04186598 record still lists
NCT04186598 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Continuous Positive Airway Pressure appearing as the primary indexed condition, and to 3 interventions - of which CPAP mask system is the first listed.
NCT04186598 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04186598 about?
NCT04186598 is a clinical study titled "Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema". The primary objective is to evaluate the efficacy of continuous positive pressure on resolution of high-altitude pulmonary edema vs high flow oxygen. The secondary objective is to derive an incidence of high-altitude pulmonary edema based on the elevation and timing from which the subject arrives. A...
What is the current status of trial NCT04186598?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2020-01-20. Estimated completion is 2023-09-13.
What conditions does trial NCT04186598 study?
This clinical trial studies the following conditions: Continuous Positive Airway Pressure, High Altitude Pulmonary Edema.
What interventions are being tested in trial NCT04186598?
The interventions under investigation include: CPAP mask system (DEVICE), Nifedipine 30 MG (DRUG), CPAP mask system without PEEP (DEVICE).
Who is sponsoring clinical trial NCT04186598?
This trial is sponsored by CommonSpirit Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04186598 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Continuous Positive Airway Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04186598's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI